Interferon alpha and omega antibody antagonists
US-10358491-B2 · Jul 23, 2019 · US
Interferons
Interferons · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/249 |
| Official title | {Interferons} |
| Display label | Interferons |
| Total patents | 177 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 13 |
| 2016 | 14 |
| 2017 | 15 |
| 2018 | 17 |
| 2019 | 21 |
| 2020 | 20 |
| 2021 | 11 |
| 2022 | 23 |
| 2023 | 11 |
| 2024 | 17 |
| 2025 | 11 |
| 2026 | 4 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Interferon alpha and omega antibody antagonists
US-10155809-B2 · Dec 18, 2018 · US
Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn-lambda ligands engage a novel receptor ifn-lambda r1 (crf2-12) and il-10r2 (crf2-4) for signaling and induction of biological activities
US-2018243377-A1 · Aug 30, 2018 · US
Method for the treatment of pain and osteoarthritis with c-fms antagonists
US-2018237531-A1 · Aug 23, 2018 · US
Methods of purifying antibodies
US-10047144-B2 · Aug 14, 2018 · US
Combination Immunotherapy
US-2018194825-A1 · Jul 12, 2018 · US
Method for treatment of osteoarthritis with C-Fms antagonists
US-10005840-B2 · Jun 26, 2018 · US
Cancer targets and uses thereof
US-2018155421-A1 · Jun 7, 2018 · US
Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications
US-2018142015-A1 · May 24, 2018 · US
Methods for the generation of multispecific and multivalent antibodies
US-2018127514-A1 · May 10, 2018 · US
Methods and kits for labeling, detection and isolation of foxp3+ regulatory t cells, isolated population of foxp3+ regulatory t cells thus obtained and uses thereof
US-2018106779-A1 · Apr 19, 2018 · US
Methods for the generation of multispecific and multivalent antibodies
US-9926382-B2 · Mar 27, 2018 · US
Method for increasing interferon activity in an individual
US-9907832-B2 · Mar 6, 2018 · US
Interferon alpha and omega antibody antagonists
US-9902770-B2 · Feb 27, 2018 · US
Methods of treating inflammatory bowel disease with ifn-gamma therapy
US-2018051078-A1 · Feb 22, 2018 · US
Methods of treatment using an interferon gamma inhibitor
US-2018030132-A1 · Feb 1, 2018 · US
Use of cxcr3 inhibitors for protecting against fetal wastage
US-2018022810-A1 · Jan 25, 2018 · US
Interferon Alpha and Omega Antibody Antagonists
US-2018002418-A1 · Jan 4, 2018 · US
Interferon alpha antibodies and their uses
US-2017369568-A1 · Dec 28, 2017 · US
Methods for the generation of multispecific and multivalent antibodies
US-9834615-B2 · Dec 5, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/249?
- CPC C07K16/249 is the Cooperative Patent Classification code for “Interferons.”
- How many patents are filed under CPC C07K16/249 (Interferons)?
- Our database includes 177 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/249 growing?
- Publication counts under this code: 17 in 2024 vs 11 in 2025 (latest complete years).